Thymidylate synthase inhibitors in colorectal cancer.
Cassidy
J
J
University of Aberdeen, Aberdeen Royal Infirmary, Institute of Medical Sciences, Foresterhill, UK.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005492:Folic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005971:Glutamates / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000068437:Pemetrexed; D011799:Quinazolines / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D005971:Glutamates; D011799:Quinazolines; D013876:Thiophenes; C094299:ZD 9331; D000068437:Pemetrexed; D006147:Guanine; C031662:CB 3717; D005492:Folic Acid; D013940:Thymidylate Synthase; C068874:raltitrexed; C099178:nolatrexed